Iveta Tasheva* and Lubomir Dosev
Received: August 28, 2023; Published: October 26, 2023
*Corresponding author: Iveta Tasheva, PhD, Hospital SofiaMed, Sofia University, Bulgaria
DOI: 10.26717/BJSTR.2023.53.008411
Aim: The aim of this study is to report our experience in endovascular treatment of superior and inferior vena cava syndrome.
Methods: Between June 2013 and August 2019, 52 patients (mean age 54.75 years; minimum 20yo, maximum 81yo) were endovascularly treated with self-expandable stents of stenosed superior (78.8% - 41 pts) or inferior (21.2% - 11 pts) vena cava. All patients presented with vena cava obstruction syndrome. Complete occlusion was found in 30.8% - 16pts and mean percent of stenosis was 89.92%. The two main causes of the caval obstructions were carcinoma (82.7%, 43pts) and thrombophilia (7.7%, 4 pts) (Figure 1).
• Treatment and complications Successful procedures were 97.8%.
• Balloon predilataion.
• Stent placement – self expandable stents (Sinus XL, Protégé, Abre).
• Balloon postdilation.
• Two major complications (3.8%).
• Thrombus migration causing pulmonary embolism (Figure 2).
Both of them treated endovascularly with thrombus fragmentation, local fibrinolysis and aspiration. In nearly all patients stents were placed (97.8%) and there was clinical improvement of the caval syndrome- considerable reduction of edema and symptom relief in the treated patients. Of all 52 procedures we had two major intra-procedural complications (3.8%) – both migration of thrombus material causing pulmonary embolism, which was treated with intrapulmonary thrombus fragmentation and thrombolysis. All patients were clinically followed-up; 59.6% were followed-up by CT scan or flow Doppler ultrasound up to 65 months after procedure, with a median follow up period of 1 month (30-1950 days). Stent patency was 93.5% (29 pts); significant stent restenosis or occlusion were found in 2 cases (6.5%) and were successfully treated endovascularly (Figure 3).
• All patients had relief of vena cava syndrome.
• All patients were clinically followed up – up to 65 months.
• Median follow up period was 1 month (30-1950 days).
• CT - scan or Doppler ultrasound follow up was done in 59.6% of patients (Figure 4) [1-4].
Endovascular treatment with stent implantation for superior and inferior vena cava syndrome is a minimal invasive and safe procedure with favorable clinical effect and satisfactory mid-term result.